Form 4 for TARS Tarsus Pharmaceuticals, Inc.
Accepted 2023-06-21 00:00:00 ET · period of report 2023-06-16 · accession 0001819790-23-000041 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2023-06-21 | 2023-06-16 | TARS | LINK WILLIAM J PHD | Dir | M - OptEx | — | +2,000 | 136.6K | +1% | — |
| D | 2023-06-21 | 2023-06-16 | TARS | LINK WILLIAM J PHD | Dir | M - OptEx | $0.00 | -2,000 | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-06-16 | M | A | 2,000 | — | 136,632 | D | — | — | (F1) The shares were issued pursuant to settlement of vested Restricted Stock Units ("RSUs"). Each RSU represents a contingent right to receive one share of the Company's common stock. |
| 2 | Derivative | Restricted Stock Units | 2023-06-16 | M | D | 2,000 | $0.00 | 0 | D | — · — to — | 2,000 Common Stock | (F2) Each RSU represents a contingent right to receive one share of the Company's common stock. (F3) RSUs granted on June 16, 2022, in connection with the Reporting Person's service as a non-employee director as of the Company's 2022 annual meeting of stockholders. The RSUs vest in full on the one-year anniversary of the date of grant, subject to the non-employee director's continuous service. |